Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Impel Pharmaceuticals Inc. IMPL

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.


Top institutional share ownership of Impel NeuroPharma, Inc.

Name Shares Shares % change Value Value % change
Kohlberg Kravis Roberts & Co. L.P. 4,135,971 0.0% $20,142 -47.8%
5AM Venture Management, LLC 2,884,791 0.0% $14,049 -47.8%
Vivo Capital, LLC 2,884,789 0.0% $14,049 -47.8%
venBio Partners LLC 2,759,791 0.0% $13,440 -47.8%
Vanguard Group Inc 513,868 0.0% $2,503 -47.8%
DCF Advisers, LLC 469,183 7.0% $2,285 -44.1%
Lasry Marc 408,329 0.0% $1,989 -47.7%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 396,809 0.0% $1,932 -47.8%
Opaleye Management Inc. 255,250 76.5% $1,243 -7.8%
Geode Capital Management, Llc 148,646 29.1% $723 -32.6%

Top institutional buyers of Impel NeuroPharma, Inc.

Name Shares % change Value % change Shares Value
Opaleye Management Inc. 76.5% -7.8% 255,250 $1,243
FSSNX - Fidelity Small Cap Index Fund 46.2% 6.4% 47,230 $299
IBB - iShares Nasdaq Biotechnology ETF 35.1% -29.5% 76,717 $374
Geode Capital Management, Llc 29.1% -32.6% 148,646 $723
BlackRock Inc. 10.0% -42.4% 107,254 $523
DCF Advisers, LLC 7.0% -44.1% 469,183 $2,285
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock 4.0% 18.3% 52,175 $408
Gilder Gagnon Howe & Co Llc 3.9% -45.8% 142,696 $695
Bank of New York Mellon Corp 0.8% -47.4% 35,301 $172

Top institutional sellers of Impel NeuroPharma, Inc.

Name Shares % change Value % change Shares Value
Millennium Management Llc -77.9% -88.5% 31,842 $155
Ergoteles LLC -13.9% -55.1% 24,447 $119
BRSIX - Ultra-Small Company Market Fund Class N -13.3% -54.8% 65,000 $317
Bridgeway Capital Management Inc -12.8% -54.4% 68,300 $333
SBIO - ALPS Medical Breakthroughs ETF -12.3% -16.4% 22,298 $154
FSMAX - Fidelity Extended Market Index Fund -1.2% 11.9% 32,603 $255

Information provided by Fintel.io